In this context, a recent study suggests that experimental depletion of Mettl3 in mesenchymal stem cells could lead to the development of osteoporosis in a mice model [290], while its upregulation provides protection against osteoporosis triggered by estrogen deficiency. Here, METTL3 is linked to osteoporosis.